EARNEST Partners’s Biogen BIIB Stock Holding History

EARNEST Partners’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-82	Closed	-$21.1K	–	381
2023 Q3	$21.1K	Hold	82	–	–	﹤0.01%	488
2023 Q2	$23.4K	Hold	82	–	–	﹤0.01%	455
2023 Q1	$22.8K	Hold	82	–	–	﹤0.01%	457
2022 Q4	$22.7K	Hold	82	–	–	﹤0.01%	460
2022 Q3	$22K	Hold	82	–	–	﹤0.01%	429
2022 Q2	$17K	Hold	82	–	–	﹤0.01%	488
2022 Q1	$17K	Hold	82	–	–	﹤0.01%	523
2021 Q4	$20K	Hold	82	–	–	﹤0.01%	499
2021 Q3	$23K	Hold	82	–	–	﹤0.01%	444
2021 Q2	$28K	Hold	82	–	–	﹤0.01%	412
2021 Q1	$23K	Hold	82	–	–	﹤0.01%	434
2020 Q4	$20K	Hold	82	–	–	﹤0.01%	443
2020 Q3	$23K	Hold	82	–	–	﹤0.01%	386
2020 Q2	$22K	Sell	82 -20	-20%	-$6.01K	﹤0.01%	380
2020 Q1	$32K	Hold	102	–	–	﹤0.01%	323
2019 Q4	$30K	Hold	102	–	–	﹤0.01%	376
2019 Q3	$24K	Hold	102	–	–	﹤0.01%	404
2019 Q2	$24K	Hold	102	–	–	﹤0.01%	412
2019 Q1	$24K	Hold	102	–	–	﹤0.01%	404
2018 Q4	$31K	Hold	102	–	–	﹤0.01%	355
2018 Q3	$36K	Hold	102	–	–	﹤0.01%	348
2018 Q2	$30K	Hold	102	–	–	﹤0.01%	363
2018 Q1	$28K	Hold	102	–	–	﹤0.01%	370
2017 Q4	$32K	Buy	+102	New	+$32.7K	﹤0.01%	347
2017 Q1	–	Sell	-102	Closed	-$29K	–	322
2016 Q4	$29K	Buy	+102	New	+$30.2K	﹤0.01%	341

Other funds holding BIIB

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

EARNEST Partners's BIIB Position: Q4 2023 in Review

EARNEST Partners sold out of Biogen (BIIB) in Q4 2023, closing a stake of 82 shares — an estimated $21.1K sold.

EARNEST Partners first reported a position in BIIB in Q4 2016 and held it in 25 quarters. The position peaked at $36K in Q3 2018. 1,003 funds tracked by Wall St. Rank hold BIIB as of Q4 2023.

EARNEST Partners reported no remaining Biogen position as of Q4 2023 after selling out during the quarter.
EARNEST Partners sold 82 Biogen shares in Q4 2023, an estimated $21.1K.
EARNEST Partners first reported a position in Biogen in Q4 2016 and held it in 25 quarters.
EARNEST Partners's Biogen position peaked at $36K in Q3 2018.
1,003 funds tracked by Wall St. Rank held Biogen as of Q4 2023.

Based on EARNEST Partners's 13F filing for Q4 2023, filed 14 Feb 2024.